Cipla shares: Purchase Cipla, goal value Rs 1735: Axis Securities
Cipla Ltd., included within the yr 1935, is a Giant Cap firm (having a market cap of Rs 129384.57 Crore) working in Prescription drugs sector. Cipla Ltd. key Merchandise/Income Segments embrace Prescription drugs, Royalty Revenue, Different Working Income, Export Incentives and Scrap for the yr ending 31-Mar-2023.
Financials
For the quarter ended 30-06-2024, the corporate reported a Consolidated Complete Revenue of Rs 6854.13 Crore, up 6.89 % from final quarter Complete Revenue of Rs 6412.57 Crore and up 6.02 % from final yr identical quarter Complete Revenue of Rs 6465.18 Crore. Firm reported web revenue after tax of Rs 1176.29 Crore in newest quarter. Promoter/FII Holdings
Promoters held 30.91 per cent stake within the firm as of 30-Jun-2024, whereas FIIs owned 27.82 per cent, DIIs 24.56 per cent.
(Disclaimer: Suggestions given on this part or any experiences connected herein are authored by an exterior social gathering. Views expressed are that of the respective authors/entities. These don’t characterize the views of Financial Occasions (ET). ET doesn’t assure, vouch for, endorse any of its contents and hereby disclaims all warranties, categorical or implied, regarding the identical. Please seek the advice of your monetary adviser and search impartial recommendation.
